Graves Disease Clinical Trials

126 clinical trials for Graves Disease across international registries, including 35 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease — RECRUITING · PHASE2
• A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease — RECRUITING · PHASE3
• Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy. — RECRUITING
• A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old — RECRUITING · PHASE2
• A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease — RECRUITING · PHASE2
• Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease — RECRUITING · PHASE3
• Preoperative Corticosteroids in Autoimmune Thyroid Disease — RECRUITING · PHASE4
• NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease — RECRUITING · PHASE1
• Study of BHV-1300 in Graves' Disease — RECRUITING · PHASE1
• Telehealth Music Therapy for Adults With Endocrine Disorder and Depression — RECRUITING · NA
• Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease — RECRUITING · PHASE2
• A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) — RECRUITING · PHASE2
• Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid Eye Disease: The TED SCOPE National Multicenter Registry Study — RECRUITING
• A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease. — RECRUITING · PHASE3
• A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease — RECRUITING · PHASE2
• Evaluating an AI Tool for Detecting Thyrotoxic States — RECRUITING
• In Vivo CAR-T for Refractory Graves' Disease — RECRUITING · PHASE1
• Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease — RECRUITING
• A Study of GensSci098 in Subjects With Graves' Disease — RECRUITING · PHASE1
• Impact of Thyroid Hormones on Human Glucose and Energy Metabolism — RECRUITING · NA
• Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease — RECRUITING · PHASE2
• Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease — RECRUITING · PHASE1
• Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules — RECRUITING · NA
• The Impact of Person Centred Care (PCC) in Grave's Disease — RECRUITING · NA
• Course for Brain Fatigue After Graves' Disease Controlled Study — RECRUITING · NA
• Personalized Treatment in Thyroid Disorders — RECRUITING · NA
• Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease — RECRUITING
• Prospective Evaluation of OptiThyDose — RECRUITING · NA
• Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease — RECRUITING · PHASE1
• A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China — RECRUITING
• Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis — RECRUITING
• Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease — RECRUITING
• Graves' Disease Remission Study: MycoMeth Combo — RECRUITING · PHASE2
• The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction — RECRUITING
• Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease — RECRUITING · PHASE4
• A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease — COMPLETED · PHASE2
• A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves’ Disease Inadequately Controlled With Antithyroid Drugs — NOT_YET_RECRUITING · PHASE3
• A Long-Term Extension Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Patients With Graves' Disease — TERMINATED · PHASE2
• A study to test single and multiple doses of MER511 given to adults with Graves’ disease — NOT_YET_RECRUITING · PHASE1
• Phase 1 Single Ascending and Multiple Ascending Dose Study with LCA-0321 — TERMINATED · PHASE1
• Rubus Sanctus (Wild Blackberry) Root Extract as a Dietary Supplement for Graves' Disease — COMPLETED · NA
• A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease — TERMINATED · PHASE2
• BASE-DIET: a Study on Nutritional Intervention in Patients With Graves' Disease — ACTIVE_NOT_RECRUITING · NA
• Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study — COMPLETED · NA
• Incidence of Graves' Disease After COVID-19 Vaccination — ACTIVE_NOT_RECRUITING
• Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery — WITHDRAWN
• Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz — SUSPENDED · PHASE2
• Cardiac Symptoms in Patients With Treated Graves' Disease — ACTIVE_NOT_RECRUITING
• Efficacy of Methimazole Dosing Algorithm — TERMINATED
• Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy? — TERMINATED · PHASE3

Refine this search